Literature DB >> 25131692

Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism.

Sofya Abazyan1, Eun Ju Yang, Bagrat Abazyan, Meng Xia, Chunxia Yang, Camilo Rojas, Barbara Slusher, Rita Sattler, Mikhail Pletnikov.   

Abstract

Disrupted-in-schizophrenia 1 (DISC1) is a genetic risk factor that has been implicated in major mental disorders. DISC1 binds to and stabilizes serine racemase to regulate production of D-serine by astrocytes, contributing to glutamate (GLU) neurotransmission. However, the possible involvement of astrocytic DISC1 in synthesis, metabolism, reuptake, or secretion of GLU remains unexplored. Therefore, we studied the effects of dominant-negative mutant DISC1 on various aspects of GLU metabolism by using primary astrocyte cultures and hippocampal tissue from transgenic mice with astrocyte-restricted expression of mutant DISC1. Although mutant DISC1 had no significant effects on astrocyte proliferation, GLU reuptake, glutaminase, or glutamate carboxypeptidase II activity, expression of mutant DISC1 was associated with increased levels of alanine-serine-cysteine transporter 2, vesicular glutamate transporters 1 and 3 in primary astrocytes and in the hippocampus, and elevated expression of the NR1 subunit and diminished expression of the NR2A subunit of N-methyl-D-aspartate (NMDA) receptors in the hippocampus, at postnatal day 21. Our findings indicate that decreased D-serine production by astrocytic mutant DISC1 might lead to compensatory changes in levels of the amino acid transporters and NMDA receptors in the context of tripartite synapse.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ASCT2; D-serine; NMDA; VGLUT; glutamate uptake; psychiatric disease

Mesh:

Substances:

Year:  2014        PMID: 25131692      PMCID: PMC4247786          DOI: 10.1002/jnr.23459

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  52 in total

1.  Identification of the promoter region of human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene.

Authors:  M Fukasawa; E Takayama; N Shinomiya; A Okumura; M Rokutanda; N Yamamoto; R Sakakibara
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

2.  Vesicular glutamate transporter-dependent glutamate release from astrocytes.

Authors:  Vedrana Montana; Yingchun Ni; Vice Sunjara; Xue Hua; Vladimir Parpura
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

3.  Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay.

Authors:  Camilo Rojas; Scott T Frazier; Juliet Flanary; Barbara S Slusher
Journal:  Anal Biochem       Date:  2002-11-01       Impact factor: 3.365

4.  Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain.

Authors:  I H Zwain; S S Yen
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

5.  Glial transport of the neuromodulator D-serine.

Authors:  Cátia S Ribeiro; Marcelo Reis; Rogério Panizzutti; Joari de Miranda; Herman Wolosker
Journal:  Brain Res       Date:  2002-03-08       Impact factor: 3.252

6.  Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.

Authors:  A J Law; J F Deakin
Journal:  Neuroreport       Date:  2001-09-17       Impact factor: 1.837

7.  Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.

Authors:  M B Robinson; R D Blakely; R Couto; J T Coyle
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

8.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.

Authors:  Konrad Talbot; Wess L Eidem; Caroline L Tinsley; Matthew A Benson; Edward W Thompson; Rachel J Smith; Chang-Gyu Hahn; Steven J Siegel; John Q Trojanowski; Raquel E Gur; Derek J Blake; Steven E Arnold
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Valproate increases glutaminase and decreases glutamine synthetase activities in primary cultures of rat brain astrocytes.

Authors:  R M Collins; H R Zielke; R C Woody
Journal:  J Neurochem       Date:  1994-03       Impact factor: 5.372

10.  Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia.

Authors:  M V Pletnikov; Y Ayhan; O Nikolskaia; Y Xu; M V Ovanesov; H Huang; S Mori; T H Moran; C A Ross
Journal:  Mol Psychiatry       Date:  2007-09-11       Impact factor: 15.992

View more
  9 in total

1.  Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

Authors:  Hans-Gert Bernstein; Esther Jauch; Henrik Dobrowolny; Christian Mawrin; Johann Steiner; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-28       Impact factor: 5.270

2.  DISC1 in Astrocytes Influences Adult Neurogenesis and Hippocampus-Dependent Behaviors in Mice.

Authors:  Chantelle E Terrillion; Bagrat Abazyan; Zhongxi Yang; Joshua Crawford; Alexey V Shevelkin; Yan Jouroukhin; Ki Hyun Yoo; Chang Hoon Cho; Robin Roychaudhuri; Solomon H Snyder; Mi-Hyeon Jang; Mikhail V Pletnikov
Journal:  Neuropsychopharmacology       Date:  2017-06-20       Impact factor: 7.853

3.  Cell Type-Specific Effects of Mutant DISC1: A Proteomics Study.

Authors:  Meng Xia; Jantine A C Broek; Yan Jouroukhin; Jeannine Schoenfelder; Sofya Abazyan; Hanna Jaaro-Peled; Akira Sawa; Sabine Bahn; Mikhail Pletnikov
Journal:  Mol Neuropsychiatry       Date:  2016-04-01

Review 4.  Utility and validity of DISC1 mouse models in biological psychiatry.

Authors:  T Tomoda; A Sumitomo; H Jaaro-Peled; A Sawa
Journal:  Neuroscience       Date:  2016-01-06       Impact factor: 3.590

5.  Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1.

Authors:  N Dawson; M Kurihara; D M Thomson; C L Winchester; A McVie; J R Hedde; A D Randall; S Shen; P A Seymour; Z A Hughes; J Dunlop; J T Brown; N J Brandon; B J Morris; J A Pratt
Journal:  Transl Psychiatry       Date:  2015-05-19       Impact factor: 6.222

Review 6.  Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology.

Authors:  Jiasi Li; Lei Zhang; Yongxin Chu; Michael Namaka; Benqiang Deng; Jiming Kong; Xiaoying Bi
Journal:  Front Cell Neurosci       Date:  2016-05-10       Impact factor: 5.505

7.  Familial t(1;11) translocation is associated with disruption of white matter structural integrity and oligodendrocyte-myelin dysfunction.

Authors:  Navneet A Vasistha; Mandy Johnstone; Samantha K Barton; Steffen E Mayerl; Bhuvaneish Thangaraj Selvaraj; Pippa A Thomson; Owen Dando; Ellen Grünewald; Clara Alloza; Mark E Bastin; Matthew R Livesey; Kyriakos Economides; Dario Magnani; Paraskevi Makedonopolou; Karen Burr; David J Story; Douglas H R Blackwood; David J A Wyllie; Andrew M McIntosh; J Kirsty Millar; Charles Ffrench-Constant; Giles E Hardingham; Stephen M Lawrie; Siddharthan Chandran
Journal:  Mol Psychiatry       Date:  2019-09-03       Impact factor: 15.992

8.  Tyrosine 121 moves revealing a ligandable pocket that couples catalysis to ATP-binding in serine racemase.

Authors:  Chloe R Koulouris; Sian E Gardiner; Tessa K Harris; Karen T Elvers; S Mark Roe; Jason A Gillespie; Simon E Ward; Olivera Grubisha; Robert A Nicholls; John R Atack; Benjamin D Bax
Journal:  Commun Biol       Date:  2022-04-11

Review 9.  Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.

Authors:  Ronald Kim; Kati L Healey; Marian T Sepulveda-Orengo; Kathryn J Reissner
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-06       Impact factor: 5.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.